Overall, these experiments show that stimulation of the BCR, as illustrated by the enhanced phosphorylation of BCR signaling downstream mediators detected, counteracts the cytotoxicity of EC-7072 against primary CLL cells, hence supporting that the mithralog negatively modulates tonic BCR signaling. The gene discussed is BCR; the disease is B-cell chronic lymphocytic leukemia.